How to Reconstitute Epitalon: Step-by-Step Reconstitution Guide

What Is Epitalon and Why Does Reconstitution Technique Matter?

Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) originally isolated from the bovine pineal gland by Russian researcher Vladimir Khavinson in the 1980s. It is supplied as a lyophilized (freeze-dried) powder because peptides in aqueous solution degrade rapidly through hydrolysis and oxidation. Proper reconstitution preserves peptide integrity, ensures accurate dosing, and prevents microbial contamination during the multi-dose use period.

Why Lyophilized Powder Requires Careful Handling

Lyophilization removes virtually all water from a peptide preparation, arresting chemical degradation. The USP General Chapter on Lyophilization (USP <1>) notes that reconstituted solutions are inherently less stable than dry powder and must be treated as a time-limited preparation from the moment solvent is added. Benzyl alcohol in bacteriostatic water acts as a preservative that extends the multi-dose window to approximately 28 days, which sterile water for injection cannot do. FDA guidance on bacteriostatic water confirms that benzyl alcohol at 0.9% w/v inhibits microbial growth in multi-dose preparations.

Peptide Stability: The Research Basis

Peptide degradation in solution follows first-order kinetics. A 2022 analysis in the International Journal of Pharmaceutics (PMID 35944792) confirmed that short-chain peptides stored at 4 °C in buffered aqueous solution retained greater than 95% purity for up to 30 days, while room-temperature storage accelerated degradation to measurable losses within 7 days. Keeping the reconstituted vial at 2 to 8 °C is therefore not optional.

Supplies You Need Before You Start

Gather every item before touching the vial. Interrupting the process to locate supplies increases contamination risk.

Required Materials

• One 10 mg Epitalon lyophilized powder vial
• One 10 mL or 30 mL vial of bacteriostatic water for injection (USP grade, 0.9% benzyl alcohol)
• Two 29 to 31 gauge, 0.5 mL or 1 mL insulin syringes (one for adding diluent, one for drawing doses)
• Sterile alcohol swabs (70% isopropyl alcohol)
• A clean, flat, well-lit surface
• Puncture-resistant sharps container

Why Bacteriostatic Water, Not Sterile Saline

Sterile saline (0.9% sodium chloride for injection) lacks a preservative. Each needle penetration of a septum introduces a small risk of microbial entry. The USP <797> Pharmaceutical Compounding Standards specify that multi-dose vials without antimicrobial preservatives must be discarded within 6 hours of first entry in a non-ISO classified environment. Bacteriostatic water extends that window to 28 days by suppressing bacterial growth with benzyl alcohol. Sterile water for injection is appropriate only for single-use preparations prepared in a certified ISO 5 laminar flow hood.

A 2019 review in the American Journal of Health-System Pharmacy (PMID 31403182) examined multi-dose vial contamination rates and found that benzyl-alcohol-preserved diluents reduced contamination events by more than 80% compared with non-preserved alternatives in clinical settings.

Step-by-Step Reconstitution Protocol

Follow these steps in sequence. Skipping or reordering any step increases the risk of contamination or inaccurate concentration.

Step 1: Wash Hands and Prepare the Work Area

Wash hands thoroughly with soap and water for at least 20 seconds. The CDC hand hygiene guidelines (2002, updated 2019) established that proper hand washing before any injection preparation reduces healthcare-associated infection risk. Lay a clean paper towel on a flat surface under bright light.

Step 2: Inspect Both Vials

Check the Epitalon vial for a white-to-off-white dry cake or powder. Check the bacteriostatic water vial for clarity. Discard either vial if the seal is broken, the powder appears discolored, or the water appears cloudy. FDA labeling for injectable preparations requires that all injectable products be visually inspected for particulate matter and discoloration prior to administration.

Step 3: Swab Both Vial Tops

Wipe the rubber septum of the Epitalon vial and the bacteriostatic water vial with a fresh 70% isopropyl alcohol swab. Allow 30 seconds of air-dry time. Wiping alone is insufficient if the swab is immediately followed by needle insertion because residual alcohol on the septum can carry into the vial.

Step 4: Draw the Bacteriostatic Water

Using the first insulin syringe, draw the target volume of bacteriostatic water:

• 2 mL yields a working concentration of 5 mg/mL (each 0.1 mL contains 0.5 mg)
• 1 mL yields a working concentration of 10 mg/mL (each 0.1 mL contains 1 mg)

The 5 mg/mL concentration is generally preferred for subcutaneous dosing because it allows more precise volume adjustments. With a 0.5 mL insulin syringe marked in 0.01 mL increments, a 2 mg dose equals 0.04 mL at 50 mg/mL or, at 5 mg/mL, equals 0.4 mL. The latter is far easier to measure accurately with a standard insulin syringe.

Step 5: Inject the Water Slowly Along the Vial Wall

Insert the needle into the center of the Epitalon septum at a 45-degree angle. Direct the stream of bacteriostatic water gently against the inside glass wall of the vial rather than directly onto the powder cake. Peptide reconstitution guidelines published by the American Peptide Society recommend slow, wall-directed injection to prevent foaming and mechanical shear that can disrupt disulfide bonds and secondary structure. Push the plunger slowly over 10 to 15 seconds. Do not shake.

Step 6: Swirl, Do Not Shake

Once all the water has been added, gently rotate and tilt the vial in a slow circular motion for 20 to 30 seconds. The powder should dissolve completely, producing a clear, colorless solution. Shaking introduces air bubbles and mechanical stress. A stability study on reconstituted peptide hormones (PMID 30291763) found that vortex mixing reduced peptide recovery by 3 to 7% compared with gentle swirling, attributed to aggregation at the air-liquid interface.

Step 7: Inspect the Reconstituted Solution

Hold the vial against a light source. The solution must be:

• Clear (not cloudy or milky)
• Colorless (not yellow, brown, or pink)
• Free of visible particles or fibers

Any deviation means the vial must be discarded. USP <790> Visible Particulates in Injections sets the standard for injectable clarity and prohibits administration of solutions with visible particulate matter.

Step 8: Label the Vial

Write the reconstitution date, concentration, and calculated discard date (28 days from reconstitution) directly on the vial label with a permanent marker. This step is frequently skipped and is one of the most common reconstitution errors in outpatient settings. USP <797> requires that all compounded sterile preparations carry a beyond-use date on the container label.

Step 9: Store Correctly

Place the labeled vial in the back of a household refrigerator at 2 to 8 °C. Avoid the door shelf where temperature fluctuates with each opening. Never freeze the reconstituted solution. Freezing and thawing aqueous peptide solutions promotes aggregation. A 2020 study in the Journal of Pharmaceutical Sciences (PMID 32298757) confirmed that freeze-thaw cycling of short peptides caused aggregation detectable by dynamic light scattering after a single cycle at -20 °C.

Dosing Calculator: How Much to Draw Per Dose

The table below covers the two most common reconstitution concentrations and target doses used in published Epitalon research, ranging from 2 mg to 10 mg per injection. Khavinson et al. (2012, PMID 22827579) reported a standard study protocol of 10 mg Epitalon injected subcutaneously once daily for 10 days, repeated twice yearly in aging subjects.

| Target Dose | Concentration 5 mg/mL (2 mL recon) | Concentration 10 mg/mL (1 mL recon) | |---|---|---| | 2 mg | 0.40 mL | 0.20 mL | | 5 mg | 1.00 mL | 0.50 mL | | 10 mg | 2.00 mL | 1.00 mL |

Practical note: A standard 0.5 mL (50-unit) insulin syringe holds a maximum of 0.5 mL. For a 10 mg dose at 5 mg/mL (which requires 1.0 mL total), draw two separate 0.5 mL syringes or switch to a 1 mL barrel syringe. Alternatively, the 10 mg/mL concentration keeps all common doses within a single 0.5 mL syringe.

Converting mL to Insulin-Syringe Units

Insulin syringes are marked in units calibrated for U-100 insulin (100 units per mL). One unit on a U-100 syringe equals 0.01 mL. This direct conversion is accurate for any aqueous solution and does not require adjustment.

• 0.10 mL = 10 units on a U-100 syringe
• 0.20 mL = 20 units
• 0.40 mL = 40 units
• 0.50 mL = 50 units (full barrel)

Syringe Selection by Dose Volume

For volumes of 0.20 mL or less, a 0.3 mL (30-unit) insulin syringe provides more precise graduation marks and reduces dosing error. A 2018 study in Diabetes Technology and Therapeutics (PMID 29620961) found that 0.3 mL syringes produced significantly lower injection volume variance than 1 mL syringes for volumes below 0.25 mL. Gauge of 31 is preferred over 29 for reduced injection-site discomfort, with no meaningful difference in flow rate for aqueous solutions at these volumes. A comparative trial (PMID 18837807) confirmed equivalent delivery accuracy between 29 and 31 gauge insulin needles for subcutaneous peptide volumes under 0.5 mL.

Subcutaneous Injection Technique

Once the correct volume is drawn, the injection process takes under 60 seconds.

Site Selection

Rotate among four zones to prevent lipohypertrophy: left lower abdomen, right lower abdomen, left lateral thigh, right lateral thigh. Stay at least 2 inches from the navel. FDA-approved insulin prescribing information recommends site rotation within the same anatomical region to maintain consistent subcutaneous absorption.

Injection Steps

1. Swab the skin with a fresh alcohol swab and allow 30 seconds to dry.
2. Pinch a 1-inch fold of skin between thumb and forefinger.
3. Insert the needle at 45 degrees (for lean individuals) or 90 degrees (adequate subcutaneous fat depth).
4. Release the skin fold.
5. Inject slowly over 5 seconds.
6. Withdraw the needle at the same angle it entered.
7. Apply gentle pressure with a dry swab. Do not rub.
8. Dispose of the used syringe immediately in the sharps container.

CDC injection safety guidelines specify that needles must never be recapped after use and must be disposed of in an approved sharps container to prevent needle-stick injury.

Stability, Storage, and Discard Rules

Lyophilized Powder Before Reconstitution

Store un-reconstituted Epitalon powder at -20 °C for long-term storage or at 2 to 8 °C for use within 4 to 8 weeks, per standard peptide compounding practice. A 2021 peptide stability review in Pharmaceutics (PMID 33917285) confirmed that lyophilized peptides stored below -20 °C showed no measurable degradation over 24 months, while storage at 25 °C produced significant degradation within 3 months.

Reconstituted Solution

• Refrigerate at 2 to 8 °C immediately after reconstitution.
• Discard at 28 days regardless of remaining volume.
• Discard immediately if the solution becomes cloudy, changes color, or develops visible particles at any point.
• Never return unused solution drawn into a syringe back to the vial. This practice introduces contamination.

USP <797> (2023 revision) assigns a beyond-use date of 28 days for Category 1 compounded sterile preparations (non-sterile starting materials not used) stored at controlled refrigerated temperatures when bacteriostatic preservatives are present.

Common Reconstitution Errors and How to Avoid Them

Error 1: Injecting Water Directly onto the Powder Cake

This collapses the lyophilized matrix unevenly and can cause foaming. Always direct the stream against the glass wall. Research on peptide reconstitution (PMID 28826554) documented that direct impingement on the lyophilized cake increased insoluble aggregate formation by up to 12% compared with wall-directed injection.

Error 2: Shaking the Vial

Shaking introduces air bubbles and promotes peptide aggregation at the air-liquid interface. Swirl gently. The above-referenced aggregation study (PMID 30291763) found detectable high-molecular-weight species after 30 seconds of vortex mixing in reconstituted peptide preparations.

Error 3: Using Tap Water or Distilled Water

Neither is sterile, and neither contains a preservative. Both introduce microbial contamination risk and, for distilled water, hypotonic stress to tissues at the injection site. FDA 21 CFR Part 610.12 specifies that only water for injection (WFI) meeting sterility and endotoxin standards is acceptable for parenteral preparations.

Error 4: Skipping the Visual Inspection

Reconstituted solution that appears cloudy or particulate may indicate protein aggregation, microbial growth, or incorrect diluent. USP <790> mandates visual inspection of all injectable preparations for visible particulates before administration, with rejection of any non-clear preparation.

Error 5: Storing at Room Temperature

Room-temperature storage accelerates hydrolysis. The 2022 peptide stability analysis (PMID 35944792) found that short-chain peptides stored at 25 °C lost greater than 15% purity within 14 days, versus less than 5% loss at 4 °C over the same period.

Epitalon Research Background

Epitalon was studied extensively by Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology. The primary published mechanism is telomerase activation. Khavinson et al. (2003, PMID 12937186) reported that Epitalon stimulated telomerase activity in human somatic cells in vitro, resulting in measurable telomere elongation. A subsequent human pilot study (PMID 22827579) in elderly subjects aged 60 to 80 years documented an increase in melatonin secretion and a reduction in cortisol after 10-day subcutaneous Epitalon courses administered twice yearly for 3 years.

Epitalon is not FDA-approved for any indication in the United States and is classified as a research compound. FDA has issued guidance that peptides sold for research use must not be marketed for human therapeutic use without an approved New Drug Application. Prescribers and patients should be aware of this regulatory status before use.

A 2014 study in the Annals of the New York Academy of Sciences (PMID 24329748) summarized Epitalon's effects across multiple animal models, noting a reduction in tumor incidence and an extension of mean lifespan in rodents receiving repeated Epitalon courses, though no large randomized controlled trials in humans have been completed.